IMCR - Financial Reports List - Immunocore Holdings plc - IntrinsicAlpha

Immunocore Holdings plc IMCR

Healthcare - Biotechnology - NASDAQ - GB

$ 29.29

3.52 %

$ 1.47 B

Market Cap

-28.83

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-20.43%	10.02%	24.58%
Annual Report	FY	10-K	2024-12-31	24.37%	7.60%	-18.13%
Quarterly Report	Q3	8-K	2024-09-30	28.14%	277.23%	-900.01%
Quarterly Report	Q2	8-K	2024-06-30	24.66%	34.84%	19.81%
Quarterly Report	Q1	8-K	2024-03-31	28.06%	-18.40%	-23.26%
Quarterly Report	Q4	8-K	2023-12-31	119.79%	-4.82%	-15.52%
Annual Report	FY	10-K	2023-12-31	73.53%	-34.11%	-50.60%
Quarterly Report	Q3	8-K	2023-09-30	52.01%	-62.82%	90.57%
Quarterly Report	Q2	8-K	2023-06-30	89.00%	-191.23%	-45.04%
Quarterly Report	Q1	8-K	2023-03-31	144.98%	-27.97%	-30.57%

1